Skip to main content
Clinical Trials/NCT04498455
NCT04498455
Completed
Phase 4

Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency

Baylor University1 site in 1 country11 target enrollmentSeptember 30, 2018

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Weight Gain Trajectory
Sponsor
Baylor University
Enrollment
11
Locations
1
Primary Endpoint
Change in body weight
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

A randomized placebo controlled trial to determine if increased dietary fiber will prevent weight gain, inhibit adiposity and reduce perceived stress levels in residents at the Waco Family Health Center as the result of changes in distal gut microbiota composition and function.

Detailed Description

This study will utilize a single blind, placebo controlled, parallel design to assess the effect of dietary fiber \[Prebiotin\] on the gut microbiome, perceived stress, anthropometric variables, and clinical biomarkers of metabolism. All participants in this study will be resident physicians at the Family Health Center in Waco, TX. This population was selected based on pilot data indicating they are at a greater risk for weight gain and have higher levels of stress than the average population. The goal is to recruit 40 participants for a 12 week intervention trial.

Registry
clinicaltrials.gov
Start Date
September 30, 2018
End Date
February 15, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Leigh Greathouse

Assistant Professor of Nutrition Sciences

Baylor University

Eligibility Criteria

Inclusion Criteria

  • Currently a resident in training at the Family Health Center in their first year.

Exclusion Criteria

  • Pregnancy
  • Currently on prescribed metformin or NSAIDS
  • A diagnosed gastro-intestinal disease (i.e. irritable bowel syndrome or Crohn's disease)
  • Known allergy to the supplement, placebo, or provided meal replacements
  • Antibiotic use within the last 3 months.

Outcomes

Primary Outcomes

Change in body weight

Time Frame: 12 weeks

The investigators will use the following procedure to assess the effect of Prebiotin (OEI) on changes in body weight: there will be two test days: a) baseline (Day 0), prior to randomization to OEI or placebo; and b) week 12, following the 11 week course of OEI/placebo treatment. The investigators will use OEI for the inulin challenge. Change in body weight will be quantified by bio electrical impedance.

Study Sites (1)

Loading locations...

Similar Trials